-+ 0.00%
-+ 0.00%
-+ 0.00%

PharmaCyte Biotech exchanges warrants for 4,982,272 Q/C Technologies shares

PUBT·11/19/2026 22:02:25
Listen to the news
PharmaCyte Biotech exchanges warrants for 4,982,272 Q/C Technologies shares
  • PharmaCyte Biotech agreed on November 15, 2026, to exchange 851,304 Series G Long-Term Warrants for 4,982,272 Q/C Technologies common shares.
  • The exchange requires no additional consideration; shares were calculated using the warrants' Black-Scholes value divided by $0.3101 per share.
  • Q/C's Series H Convertible Preferred Stock maturity extends from March 2, 2027, to September 2, 2027, with no consideration paid.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaCyte Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008964), on November 19, 2026, and is solely responsible for the information contained therein.